Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

I see your point. The current state of either the B or K platform would fetch between $1 and $2 billion in upfront and benchmark payments (I posted platform license examples about 2 years ago, so the potential number range might actually be low). two billion might not be as much as parsing out licenses for indications, but the back end on a platform deal could be very lucrative all the while the up front payment would pay for 5 years of clinical trials in the unlicensed platform.

Thanks for reopening my eyes to that possibility. I was too focused on just Prurisol license as a result of the announced success.